Back to medications
Medication monograph

cemiplimab

Monoclonal AntibodiesPD-1/PD-L1 InhibitorsAntineoplasticsImmunotherapeutic AgentsProgrammed Death Receptor-1 Blocking Antibody

Clinical reference

Product monograph

LIBTAYO- cemiplimab-rwlc injection

Brands & formulations

Family members

LIBTAYO

Marketed
350 MGINTRAVENOUSSOLUTION[ "cemiplimab" ]
Product monograph

Classification

Chemical class
Monoclonal Antibodies, PD-1/PD-L1 Inhibitors
Clinical class
Antineoplastics, Immunotherapeutic Agents
Banks class
Programmed Death Receptor-1 Blocking Antibody